Maartje van den Biggelaar/sanquin.nl
Aug 2, 2026, 08:27
Maartje van den Biggelaar: HemoTwin Opens Doors for Aspiring Researchers
Maartje van den Biggelaar, Head of Laboratory of Proteomics at Sanquin, Lecturer of Pharmaceutical Biotechnology at Utrecht University, shared a post on LinkedIn:
“Within the national phramework of HemoTwin, we are looking for 3 PhD students to advance precision hemostasis in congenital bleeding disorders and bleeding disorders of unknown cause using mass spectrometry-based proteomics.
Join our team!”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 12:12Issac Cheong: POCUS Detection of IVC Filter Thrombosis With Right Atrial Extension
-
Nov 13, 2026, 11:57Dianne E. van der Wal: Red Blood Cell Engineering and the Role of Cytokine Glycosylation
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?